Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	35.11	111.08	82.22
Graham Fair Price	-10.19	22.58	25.14
PEG	-29.28	-1.84	-1.43
Price/Book	1.30	9.28	9.16
Price/Cash Flow	242.02	-682.18	199.46
Prices/Earnings	26.32	35.65	28.22
Price/Sales	13.38	43.04	37.96
Price/FCF	242.02	-682.18	199.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.03	0.57	0.60
Operating Margin	-15.59	0.32	0.38
ROA	-25.26	0.03	0.04
ROE	0.08	0.07	-19.81
ROIC	0.05	0.03	-34.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.26	< 0.005	296473.57
Dividends QOQ	0.05	< 0.005	-98.96
EBIT QOQ	-0.19	-0.24	-27.54
EPS QOQ	-0.20	-0.19	2.29
FCF QOQ	0.76	-1.30	71.73
Revenue QOQ	-0.10	-0.10	-1.63
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	218.66	234.66	7.32
Days Sales Outstanding (DSO)	50.42	41.08	-18.53
Inventory Turnover	0.41	0.38	-6.82
Debt/Capitalization	0.40	0.46	14.05
Quick Ratio	3.27	3.40	3.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.61	18.66	0.29
Cash	9.44	11.42	20.93
Capex	-1.26	-1.37	-8.47
Free Cash Flow	0.85	-0.25	-70.30
Revenue	4.49	4.02	-10.40
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.55	4.91	7.82
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.16	7.68	84.42
Naive Interpretation	Member

06 - Financial Health · Bad

Rating